| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824869 | Clinical Therapeutics | 2014 | 7 Pages |
Abstract
The inability of pharmaceutical and biotechnology companies to consistently embrace and coordinate sourcing strategies is creating internal friction and inefficiency. As a result, the expected impact of strategic outsourcing relationships on drug development performance, quality, and cost remains elusive.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Kenneth A. MBA, Mary Jo PhD, Kenneth I. PhD,